Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin -The CLEAR PLATELETS-2 Study
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Bivalirudin; Eptifibatide
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Biomarker; Pharmacodynamics
- Acronyms CLEAR-PLATELETS-2
- 24 Feb 2009 Results published in Journal of the American College of Cardiology 53: 648-657, No. 8, 24 Feb 2009.
- 06 Nov 2007 Status changed from recruiting to completed.
- 06 Jul 2007 Interim results have been presented.